Prothena Reports Third Quarter 2025 Financial Results and Business Highlights November 6, 2025 Net cash used in operating and investing activities was $40.6 million and $140.4 million for the third quarter and first nine months of 2025, respectively; quarter-end cash and restricted cash position was $331.7 million Roche to initiate the Phase 3 PARAISO clinical trial evaluating prasinezumab, a potential first-in-class anti-alpha-synuclein antibody, for early-stage Parkinson's disease by end of 2025 Novo Nordisk initiated the Phase 3 CLEOPATTRA clinical trial evaluating coramitug, a potential first-in-class amyloid depleter, for ATTR amyloidosis with cardiomyopathy Novo Nordisk to present Phase 2 results for coramitug during a late-breaking session at the American Heart Association Scientific Sessions on November 10, 2025 Bristol Myers Squibb obtained Fast Track designation from the U.S. FDA for BMS-986446 (PRX005), an anti-MTBR-tau-targeting antibody, for the treatment of Alzheimer’s disease Prothena will convene an Extraordinary General Meeting on November 19, 2025 to obtain shareholder approval on a proposal reducing share capital to create distributable reserves to support a share redemption program to be conducted in 2026 if deemed appropriate Potential to earn up to $105 million in aggregate clinical milestone payments by end of 2026 related to the advancement of coramitug for ATTR amyloidosis with cardiomyopathy by Novo Nordisk and PRX019 for neurodegenerative diseases by Bristol Myers Squibb
What does the Bank’s rate decision mean for your finances? November 6, 2025 UK households who were hoping for a rate cut today may be disappointed after the Bank of England held interest rates at four per cent. The decision came amid concerns surrounding high inflation ahead of Chancellor Rachel Reeves’ crunch Budget later this month. Governor Andrew Bailey, who had the deciding vote, said he would “prefer [...]
Tallest skyscraper outside London approved in £1bn project November 6, 2025 A £1bn project which will see the tallest UK skyscraper outside of London constructed in Greater Manchester has been approved. Developer Henley Investment Management has secured permission from Salford City Council for its scheme at Regent Retail Park in Ordsall Lane. The proposals include a 78-storey tower which, at 895ft (272m) tall, will be the [...]
From insights to impact, Leinster Rugby leverages data strategy to level up fan experience November 6, 2025 BearingPoint supports the club in creating a roadmap for personalized experiences and future-ready innovation.
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights November 6, 2025 SANRECO Phase 2 study of divesiran in polycythemia vera (PV) fully enrolled; topline results anticipated in 3Q 2026 Strong balance sheet and cash runway into 2028
Rachel Reeves must resign if she hikes income tax November 6, 2025 Exactly a year ago today, which was exactly a week after Rachel Reeves’ first Budget – I wrote that the Chancellor’s policies would give Brits the hangover from hell. So, one year on, how are you feeling? My reference to a hangover was inspired by the government’s absurd post-Budget boast that they’d taken a penny [...]
Labour should pull it’s Employment Rights Bill before it becomes the Unemployment Act November 6, 2025 Labour’s new law will mean a new starter can show up at work at 9am and file a costly claim against their boss by lunchtime, says Andrew Griffith MPs debated amendments to Labour’s so-called Employment Rights Bill yesterday. Employers are dreading this Bill. Written by and for the trade unions, it poses a dire threat to businesses [...]
BT bets on budget provider amid broadband customer losses November 6, 2025 BT has lost more broadband customers than expected, a sign that even its £15bn fibre rollout is struggling to retain customers from drifting to cheaper rivals. Openreach, BT’s network arm, reported a net loss of 242,000 broadband lines in the second quarter of its financial year, worse than the 205,000 analysts had pencilled in. The [...]
TITAN Group: Nine-Month 2025 Results November 6, 2025 Regulatory News: Titan SA (Euronext Brussels, ATHEX and Euronext Paris, TITC) announces the nine-month 2025 financial results. Record nine-month EBITDA profitability and a positive outlook Group Sales YTD increased by 1.4%, at €2,013m, thanks to the strong performance in Greece, in the US & in Egypt, driven by increased volumes and overall firm pricing levels. [...]
SES Delivers Solid 9 Months and Q3 2025 Results November 6, 2025 SES S.A. fully consolidates Intelsat from 17 July 2025 and announces financial results for the nine months and three months ended 30 September 2025 with solid operational and financial performance. Solid 9 months 2025 financial performance on a reported basis (Intelsat fully consolidated from 17 July 2025) Revenue of €1,747 million (+19.8% yoy(1)) and Adjusted [...]